Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 09:35 am Sale | 2023-12-31 | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 2,752,420 4.800% | -226,000 (-7.59%) | Filing History |
| 2024-02-12 5:32 pm Purchase | 2023-12-31 | 13G | Merus N.V. MRUS | Deerfield Mgmt, L.P. | 3,019,901 5.230% | 639,463 (+26.86%) | Filing History |
| 2024-02-08 10:05 am Sale | 2023-12-29 | 13G | Merus N.V. MRUS | WELLINGTON MANAGEMENT GROUP LLP | 2,009,403 3.480% | -1,680,949 (-45.55%) | Filing History |
| 2024-01-18 10:19 am Purchase | 2023-12-31 | 13G | Merus N.V. MRUS | FEDERATED HERMES INC. FHI | 3,637,309 6.300% | 1,498,609 (+70.07%) | Filing History |
| 2023-08-14 4:39 pm Purchase | 2023-08-09 | 13D | Merus N.V. MRUS | INCYTE CORP INCY | 4,004,544 6.900% | 454,544 (+12.80%) | Filing History |
| 2023-03-10 10:42 am Sale | 2023-02-28 | 13G | Merus N.V. MRUS | FEDERATED HERMES INC. FHI | 2,138,700 4.620% | -1,785,595 (-45.50%) | Filing History |
| 2023-02-14 4:05 pm Purchase | 2022-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Commodore Capital LP | 2,732,567 5.900% | 2,732,567 (New Position) | Filing History |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | Merus N.V. MRUS | BAKER BROS. ADVISORS LP | 0 0.000% | -2,037,469 (Position Closed) | Filing History |
| 2023-02-14 12:03 pm Sale | 2022-12-31 | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 2,978,420 6.400% | -1,156,651 (-27.97%) | Filing History |
| 2023-02-10 09:36 am Sale | 2022-12-31 | 13G | Merus N.V. MRUS | Deerfield Mgmt, L.P. | 2,380,438 5.140% | -141,115 (-5.60%) | Filing History |
| 2023-02-06 2:43 pm Purchase | 2022-12-30 | 13G | Merus N.V. MRUS | WELLINGTON MANAGEMENT GROUP LLP | 3,690,352 7.970% | 535,801 (+16.99%) | Filing History |
| 2023-02-01 11:06 am Purchase | 2022-12-31 | 13G | Merus N.V. MRUS | FEDERATED HERMES INC. FHI | 3,924,295 8.480% | 244,995 (+6.66%) | Filing History |
| 2022-09-30 3:29 pm Purchase | 2022-09-20 | 13G | Merus N.V. MRUS | Deerfield Mgmt, L.P. | 2,521,553 5.500% | 2,521,553 (New Position) | Filing History |
| 2022-05-16 4:30 pm Purchase | 2022-05-06 | 13G | Merus N.V. MRUS | Commodore Capital LP | 2,242,224 5.100% | 2,242,224 (New Position) | Filing History |
| 2022-02-14 4:10 pm Purchase | 2021-12-31 | 13G | Merus N.V. MRUS | Boxer Capital LLC | 1,900,000 4.400% | 300,000 (+18.75%) | Filing History |
| 2022-02-14 1:09 pm Purchase | 2021-12-31 | 13G | Merus N.V. MRUS | FEDERATED HERMES INC. FHI | 3,679,300 8.510% | 742,502 (+25.28%) | Filing History |
| 2022-02-11 7:22 pm Sale | 2021-12-31 | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 4,135,071 9.600% | -925,000 (-18.28%) | Filing History |
| 2022-02-04 09:12 am Sale | 2021-12-31 | 13G | Merus N.V. MRUS | WELLINGTON MANAGEMENT GROUP LLP | 3,154,551 7.390% | -1,445,807 (-31.43%) | Filing History |
| 2021-08-10 07:57 am Purchase | 2021-07-30 | 13G | Merus N.V. MRUS | WELLINGTON MANAGEMENT GROUP LLP | 4,600,358 12.000% | 3,470,723 (+307.24%) | Filing History |
| 2021-07-07 4:35 pm Sale | 2021-07-02 | 13G | Merus N.V. MRUS | BIOTECHNOLOGY VALUE FUND L P | 5,060,071 13.200% | -745,500 (-12.84%) | Filing History |